Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Revolution Medicines Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
RVMD
Nasdaq
8731
https://www.revmed.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Revolution Medicines Inc
Revolution Medicines Announces Publication on the Discovery of and Translational Research for RMC-6236, an Investigational RAS(ON) Multi-Selective Tri-Complex Inhibitor Designed to Block Full Spectrum of Oncogenic RAS(ON) Proteins
- Apr 9th, 2024 7:34 pm
Revolution Medicines Announces Publications on the Discovery and Preclinical Profile of Representative of a New Class of RAS(ON) Multi-Selective Inhibitors Designed to Block Full Spectrum of Oncogenic RAS(ON) Proteins
- Apr 8th, 2024 3:36 pm
Revolution Medicines to Participate in Upcoming Investor Conferences
- Apr 4th, 2024 8:05 pm
Revolution Medicines to Deliver Multiple Presentations at the Upcoming American Association for Cancer Research Annual Meeting 2024
- Mar 28th, 2024 8:05 pm
Revolution Medicines, Inc. (NASDAQ:RVMD) Q4 2023 Earnings Call Transcript
- Feb 28th, 2024 3:41 pm
Revolution Medicines Full Year 2023 Earnings: Misses Expectations
- Feb 28th, 2024 11:27 am
Q4 2023 Revolution Medicines Inc Earnings Call
- Feb 27th, 2024 3:26 pm
Revolution Medicines, Inc. (RVMD) Reports Q4 Loss, Lags Revenue Estimates
- Feb 26th, 2024 10:20 pm
Revolution Medicines Inc (RVMD) Reports Earnings: R&D Investments Surge Amidst Clinical Progress
- Feb 26th, 2024 9:32 pm
Revolution Medicines Reports Fourth Quarter and Full Year 2023 Financial Results and Update on Corporate Progress
- Feb 26th, 2024 9:05 pm
Revolution Medicines to Report Financial Results for Fourth Quarter and Full Year 2023 After Market Close on February 26, 2024
- Feb 20th, 2024 9:05 pm
Wall Street Analysts See a 27.5% Upside in Revolution Medicines, Inc. (RVMD): Can the Stock Really Move This High?
- Jan 17th, 2024 2:55 pm
Carnival upgraded, PayPal downgraded: Wall Street's top analyst calls
- Jan 5th, 2024 2:37 pm
Revolution Medicines to Present at 42nd Annual J.P. Morgan Healthcare Conference
- Jan 4th, 2024 12:00 pm
Revolution Medicines Inc Insider Sells Shares
- Dec 21st, 2023 12:01 pm
Pharma’s Frontline: 3 Stocks Driving Revolutionary Drug Development
- Dec 15th, 2023 10:04 pm
Insider Sell Alert: COO Margaret Horn Sells 5,000 Shares of Revolution Medicines Inc (RVMD)
- Dec 10th, 2023 10:05 pm
A great week that adds to Revolution Medicines, Inc.'s (NASDAQ:RVMD) one-year returns, institutional investors who own 74% must be happy
- Nov 17th, 2023 12:13 pm
3 Biotech Stocks That Could Boom or Bust by 2025
- Nov 16th, 2023 10:35 pm
Revolution Medicines Completes Acquisition of EQRx
- Nov 9th, 2023 2:10 pm
Scroll